Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

The FDA Has Lifted The Clinical Hold On Pharvaris' Investigational New Drug Application For Deucrictibant For Prophylactic Treatment Of Hereditary Angioedema Attacks Following The Review Of Data From A 26-week Rodent Toxicology Study

Author: Benzinga Newsdesk | January 22, 2024 07:52am

Posted In: PHVS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist